Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) was $5.11 for the day, up 4.29% from the previous closing price of $4.90. In other words, the price has increased by $4.29 from its previous closing price. On the day, 1.04 million shares were traded. AMLX stock price reached its highest trading level at $5.1651 during the session, while it also had its lowest trading level at $4.8335.
Ratios:
Our analysis of AMLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 6.67 and its Current Ratio is at 6.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On November 18, 2024, Robert W. Baird Upgraded its rating to Outperform which previously was Neutral and also upped its target price recommendation from $3 to $11.
BofA Securities Upgraded its Neutral to Buy on October 23, 2024, whereas the target price for the stock was revised from $4.20 to $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 455219744 and an Enterprise Value of 277795584. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.21 while its Price-to-Book (P/B) ratio in mrq is 2.13. Its current Enterprise Value per Revenue stands at 3.179 whereas that against EBITDA is -0.955.
Stock Price History:
The Beta on a monthly basis for AMLX is -0.59, which has changed by 1.5550001 over the last 52 weeks, in comparison to a change of 0.09969199 over the same period for the S&P500. Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 35.15%, while the 200-Day Moving Average is calculated to be 40.29%.
Shares Statistics:
AMLX traded an average of 796.87K shares per day over the past three months and 839370 shares per day over the past ten days. A total of 68.63M shares are outstanding, with a floating share count of 66.62M. Insiders hold about 25.22% of the company’s shares, while institutions hold 56.20% stake in the company. Shares short for AMLX as of 1744675200 were 4312023 with a Short Ratio of 5.41, compared to 1741910400 on 3747333. Therefore, it implies a Short% of Shares Outstanding of 4312023 and a Short% of Float of 5.3400002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
